Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study

BACKGROUND: To get insight in the prevalence of high, or low/no serum infliximab trough levels in patients with low disease activity and if serum trough levels are stable and reliable longitudinally we conducted a prospective cohort study METHODS: In a longitudinal, observational cohort of RA patien...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Maas, Aatke, van den Bemt, Bart JF, Wolbink, Gertjan, van den Hoogen, Frank HJ, van Riel, Piet LCM, den Broeder, Alfons A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520787/
https://www.ncbi.nlm.nih.gov/pubmed/23006627
http://dx.doi.org/10.1186/1471-2474-13-184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520787/
https://www.ncbi.nlm.nih.gov/pubmed/23006627
http://dx.doi.org/10.1186/1471-2474-13-184

Ejemplares similares